Alerts will be sent to your verified email
Verify EmailHESTERBIO
Hester Biosciences
|
SMS Pharmaceuticals
|
Bajaj Healthcare
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.91 % | 1.61 % | 0.35 % |
Financials
|
|||
5 yr Average ROE
|
10.99 % | 9.06 % | 9.93 % |
5yr average Equity Multiplier
|
2.14 | 1.9 | 2.26 |
5yr Average Asset Turnover Ratio
|
0.46 | 0.64 | 0.95 |
5yr Avg Net Profit Margin
|
11.57 % | 7.28 % | 3.65 % |
Price to Book
|
5.91 | 3.17 | 3.17 |
P/E
|
49.4 | 29.32 | 31.44 |
5yr Avg Cash Conversion Cycle
|
60.38 Days | 93.25 Days | 15.4 Days |
Inventory Days
|
100.79 Days | 116.73 Days | 51.52 Days |
Days Receivable
|
89.02 Days | 93.46 Days | 72.17 Days |
Days Payable
|
127.62 Days | 85.64 Days | 83.01 Days |
5yr Average Interest Coverage Ratio
|
6.96 | 4.77 | 7.11 |
5yr Avg ROCE
|
11.14 % | 12.12 % | 24.2 % |
5yr Avg Operating Profit Margin
|
22.71 % | 17.98 % | 16.67 % |
5 yr average Debt to Equity
|
0.75 | 0.53 | 0.86 |
5yr CAGR Net Profit
|
-4.4 % | 9.56 % | n/a |
5yr Average Return on Assets
|
5.28 % | 4.75 % | 5.32 % |
Shareholdings
|
|||
Promoter Holding
|
53.73 % | 66.26 % | 59.19 % |
Share Pledged by Promoters
|
0.0 | 32.49 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 2.09 % | -8.11 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.03 % | 3.03 % | 1.66 % |
Hester Biosciences
|
SMS Pharmaceuticals
|
Bajaj Healthcare
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
Capex
|
Capex
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|